FdaApplication
NDA 022522
Identifiers
- fda_app_no: NDA022522
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2011-02-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DALIRESP | ROFLUMILAST | 500MCG | TABLET;ORAL |
| DALIRESP | ROFLUMILAST | 250MCG | TABLET;ORAL |
2 products